Clinical Oncology Pharmacist BWH
Brigham and Women's Hospital, Inc.
Boston, MA, US
Onsite
2026-06-21
Typical pay for this role in Boston
$133K - $197K
Low
$133K
Median
$161K
High
$197K
Official salary benchmark · BLS OEWS 2025
Job description
Site: The Brigham and Women's Hospital, Inc.
Mass General Brigham relies on a wide range of professionals, including doctors, nurses, business people, tech experts, researchers, and systems analysts to advance our mission. As a not\-for\-profit, we support patient care, research, teaching, and community service, striving to provide exceptional care. We believe that high\-performing teams drive groundbreaking medical discoveries and invite all applicants to join us and experience what it means to be part of Mass General Brigham.
**Job Summary**
Mass General Brigham Cancer Institute is at the forefront in providing specialized, coordinated cancer care. Our doctors are experienced in treating
the rarest and most complex cases using the latest advancements in technology—including CAR T\-cell therapy and proton therapy—to provide personalized and innovative care. Mass General Brigham Cancer Institute unites leading experts and resources across our academic medical centers, Mass General Hospital and Brigham and Women’s Hospital, making it one of the nation’s top providers of cancer care. Our locations extend throughout New England and provide patients with comprehensive, community\-based cancer care and access to the expertise of world\-renowned cancer specialists.
Responsible for the optimization of drug therapy by identification, resolution, and prevention of drug related problems and improving therapeutic outcomes. Also responsible for providing patient care according to the laws and regulations governing pharmacists and the practice of pharmacy by the appropriate state and federal agencies.
Principal Antineoplastic Stewardship Duties and Responsibilities
1\. Develops, enforces, and maintains policies and procedures that promote and enhance patient outcomes through safe,
effective, cost\-efficient, and appropriate medication therapy use for patients receiving antineoplastic therapy.
2\. Coordinates programs designed to minimize medicat